TrialReader


Basophil Activation Test to Diagnose Food Allergy

NCT03309488 — Unknown, 600 participants, King's College London

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT03309488, acronym BAT2
StatusUnknown
Study typeObservational
Enrollment600 (Estimated)
SponsorKing's College London (Other); collaborators: Guy's and St Thomas' NHS Foundation Trust
ConditionsFood Allergy, Food Allergy in Infants, Food Allergy in Children, Food Allergen Sensitisation, Milk Allergy, Egg Allergy, Nut Allergy
InterventionsOral food challenge (Diagnostic test)
Datesstart 2018-01-30, primary completion 2021-07-31 (estimated), completion 2021-07-31 (estimated), first posted 2017-10-13, last updated 2020-09-02
Locations1 site in United Kingdom

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Food Allergy All trials for Food Allergy in Infants All trials of Oral food challenge

-Summary

The BAT II Study is a cross-sectional diagnostic study in which children with suspected IgE-mediated allergy to foods (namely cow's milk, egg, sesame and cashew), as defined by a history of an immediate-type allergic reaction to a food or no history of food consumption or the presence of food-specific IgE as documented by skin prick test or serum specific IgE, will undergo a diagnostic work-up to confirm or refute the diagnosis of IgE-mediated food allergy. Participants will be prospectively recruited from specialised Paediatric Allergy clinics in London and will undergo skin prick testing (SPT), specific IgE testing to allergen extracts and allergen components, basophil activation test (BAT) and oral food challenge. The diagnostic accuracy of the BAT and of other allergy tests will be assessed against the clinical gold-standard.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Food allergicDiagnostic Test: Oral food challengePatients with a positive oral challenge to the food being studied.
Non food allergicDiagnostic Test: Oral food challengePatients with a negative oral challenge to the food being studied.
  • Oral food challenge (Diagnostic test), also known as Basophil activation test, Skin prick test, Specific IgE test: Patients with suspected food allergy will undergo clinical and dietary assessments and oral food challenge. Different allergy tests will be performed, including skin prick test, specific IgE test and basophil activation test, and its diagnostic utility will be determined against the clinical gold-standard.

+Outcome measures

Primary outcomes

  • Diagnostic accuracy of the basophil activation test (for each individual food allergy) [3 years]: Accuracy of %CD63+ basophils

Secondary outcomes

  • Diagnostic accuracy of SPT, specific IgE to extracts and to single allergens [3 years]: Accuracy of weal diameter or level of IgE
  • Association between BAT and severity of symptoms during challenges [3 years]: Correlation between %CD63+ basophils and severity grade
  • Association between BAT and threshold of reactivity during challenges [3 years]: Correlation between CD-sens and cumulative threshold dose

+Eligibility

Sex: All, ages: 6 Months to 16 Years

Inclusion Criteria:

1. Children ≥6 months and <16 years old;
2. Suspected IgE-mediated food allergy defined by:

   * History of an immediate-type allergic reaction to a specific food or
   * No history of consumption of the specific food or
   * IgE sensitisation documented by skin prick test (≥1 mm) or serum specific IgE (≥0.10 KU/L);
3. Avoidance of the specific food for at least 2 days prior to blood collection for BAT and specific IgE and prior to the challenge;
4. Informed consent obtained from parent or guardian and assent obtained from the child.

Exclusion Criteria:

1. Clinically significant chronic illness other than atopic diseases;
2. Previous history of severe life-threatening reaction to the suspected food with documented decrease in oxygen saturation (<90%), hypotension (≥20% reduction in systolic blood pressure) and/or admission to intensive care;
3. Unwillingness to comply with study procedures, namely to undergo a diagnostic food challenge;
4. Contra-indication for diagnostic food challenge, namely:

   * Uncontrolled atopic diseases (e.g. eczema, asthma, rhinitis);
   * Chronic medical conditions that pose significant risk in the event of anaphylaxis or treatment of anaphylaxis (e.g. cardiac disease, severe lung disease, pregnancy, mastocytosis);
   * Inability to discontinue medications that might interfere with assessment or safety (e.g. antihistamines, β-agonists, β-blockers, NSAIDs, ACE inhibitor, antacids);
   * Recent (within 7-14 days) treatment with systemic steroids or prolonged high-dose systemic steroids or immunosuppressants;
5. Undergoing treatment with omalizumab, food allergen immunotherapy or other systemic immunomodulatory treatment;
6. Inability to stop anti-histamines prior to SPT.

+Locations (1)

FacilityCityCountryStatus
Pediatric Allergy Clinical Research Facility, Evelina Children's HospitalLondonUnited KingdomRecruiting

+Publications

  • Results publication: Bartha I, Boyd H, Foong RX, Krawiec M, Marques-Mejias A, Marshall HF, Radulovic S, Harrison F, Antoneria G, Jama Z, Kwok M, Pietraszewicz E, Eghleilib M, Ricci C, Marrs T, Lack G, Du Toit G, Santos AF. The Basophil Activation Test Is the Most Accurate Test in Predicting Allergic Reactions to Baked and Fresh Cow's Milk During Oral Food Challenges. Allergy. 2025 Oct;80(10):2861-2873. doi: 10.1111/all.16675. Epub 2025 Aug 13. PMID 40808324
  • Results publication: Marques-Mejias A, Radulovic S, Foong RX, Bartha I, Krawiec M, Kwok M, Jama Z, Harrison F, Ricci C, Lack G, Du Toit G, Santos AF. Partial Egg Consumption Modifies the Diagnostic Performance of Allergy Tests to Predict Outcome of Double-Blind Placebo-Controlled Food Challenges to Egg. J Allergy Clin Immunol Pract. 2024 Mar;12(3):660-669.e5. doi: 10.1016/j.jaip.2023.12.036. Epub 2023 Dec 27. PMID 38157981

+Investigators

My Notes